CTRI/2023/03/050275尚未招募不适用
An Epidemiological Study of Gerd (Gastro Esophageal Reflux Disease) in Ayurvedic Perspective and Evaluate the Efficacy of Amalaki Churna
Government Ayurvedic College and Hospital Patna Aryabhatta Knowledge University Patna Bihar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年4月3日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Reduction of acid reflux.
研究概览
简要总结
GERD is one of the most prevalent gastrointestinal disorders. The classical triad of symptoms is retrosternal burning pain (heart burn), epigastric pain and regurgitation. Present study is planned for the management of GERD in ayurvedic perspective including Amlapitta and Vidagdhajirna with the drug Amalaki Churna mentioned in Ayurveda text with the hope that it will prove more efficacious and easy to use. Total 50 patients will be registered randomly from OPD and IPD of Rog Nidan evam Vikriti Vigyan Department of Government Ayurvedic College and Hospital Patna. Duration of trial is 60 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Adaptive randomization, such as minimization
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •The Patients having age between 20- 60 years.
- •The sign and symptoms of GERD as well as Amlapitta, Vidagdhajirna based on both Ayurvedic as well as modern view.
排除标准
- •Age above 60 and less than 20 years.
- •Immunocompromised patients e.g. HIV etc.
- •Patient is unwilling.
- •Patient with complicated associated symptoms i.e. severely ill.
- •e.g. Liver cirrhosis, Adenocarcinoma.
结局指标
主要结局
Reduction of acid reflux.
时间窗: 60 Days
次要结局
- Relief in symptoms like indigestion, fatigue, nausea, sour and bitter belching, heaviness, anorexia etc.(60 Days)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
A Clinical trial to study the effect of Amalaki Churna in Gastro Esophageal Reflux Disease in Ayurvedic perspectiveCTRI/2023/03/050275Government Ayurvedic College and Hospital Patna Aryabhatta Knowledge University Patna Bihar
已完成
不适用
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen CityGastroesophageal Reflux DiseaseEpidemiologyRisk FactorsNCT06585176Zhongshan Hospital (Xiamen), Fudan University1,625
已完成
3 期
A Clinical Trial to Assess the effect of Tegoprazan in patients with Erosive Gastroesophageal Reflux DiseaseCTRI/2023/11/059403Dr. Reddy’s Laboratories Ltd.254
Unknown
不适用
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)Gastroesophageal Reflux DiseaseNCT04094402Scandinavia Pharma1,500
已完成
不适用
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal SymptomsGastroesophageal Reflux DiseaseNCT01020890AstraZeneca2,210